PDPL — Parenteral Drugs (India) Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
Annual cashflow statement for Parenteral Drugs (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,412 | -1,814 | -1,417 | -1,545 | -1,091 |
| Depreciation | |||||
| Non-Cash Items | 976 | 956 | 1,105 | 1,264 | 550 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1,864 | 4,937 | 1,262 | 1,360 | 135 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,670 | 4,770 | 1,124 | 1,253 | -4.83 |
| Capital Expenditures | -13.9 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 7.73 | 966 | 0.789 | 0.619 | 647 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.18 | 966 | 0.789 | 0.619 | 647 |
| Financing Cash Flow Items | -975 | -961 | -1,100 | -1,254 | -994 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,666 | -5,736 | -1,124 | -1,254 | -643 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.84 | 0.189 | 0.128 | -0.511 | -0.569 |